KEGG   DRUG: D05216Help
Entry
D05216                      Drug                                   

Name
Oblimersen sodium (USAN);
Genasense (TN)
Formula
C172H204N62O91P17S17. 17Na
Exact mass
6054.2294
Mol weight
6058.306
Activity
Treatment of cancer and rheumatological diseases
Remark
ATC code: 
Drug group: 
Comment
Antisense oligonucleotide
Target
BCL-2 [HSA:596] [KO:K02161]
  Pathway
hsa04210  Apoptosis  
 
Interaction
Drug interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L01 ANTINEOPLASTIC AGENTS
   L01X OTHER ANTINEOPLASTIC AGENTS
    L01XX Other antineoplastic agents
     L01XX36 Oblimersen
      D05216  Oblimersen sodium (USAN)
Antineoplastics [BR:br08308]
 Miscellaneous agents
  Other antineoplastic agents
   Oblimersen
    D05216  Oblimersen sodium (USAN)
BRITE hierarchy
Other DBs
CAS: 
190977-41-4
PubChem: 

» Japanese version   » Back

DBGET integrated database retrieval system